A new review published in the World Journal of Pediatrics provides a systematic analysis of how CHD family proteins orchestrate gene expression during heart development, offering a framework that could explain the origins of congenital heart defects and improve clinical diagnostics. The study, led by a team from China, synthesizes evidence from human genetics, animal models, and stem-cell systems to assign specific cardiac functions to different CHD proteins.
CHD proteins are chromatin remodelers that physically reshape DNA to control gene activity. The review reveals a clear division of labor among these proteins: CHD7 plays a dominant role in building the heart's early structure, CHD3 and CHD4 act as 'identity guardians' ensuring heart cells commit to the correct fate during chamber formation, and CHD8 regulates later ventricular growth and functional maturation. The authors propose three testable models—parallel, sequential, and compensatory—to explain how these remodelers may coordinate across developmental time.
The findings have direct implications for clinical practice. For genetic screening, the study provides a clear priority: CHD7 for outflow-tract defects, CHD4 for chamber-patterning anomalies, and CHD8 for ventricular dysfunction. This prioritization can improve diagnostic efficiency. Therapeutically, while directly targeting remodelers is risky due to their broad expression, identifying their downstream pathways—such as those regulating cardiomyocyte proliferation or metabolism—may offer safer drug targets. Future studies combining time-resolved multi-omics and combinatorial genetics could uncover how these proteins coordinate across development, potentially paving the way for precise, temporally controlled epigenetic therapies.
'The data show that we cannot treat these proteins as a single, interchangeable group. They have very distinct, stage-specific jobs,' the authors said. 'For example, CHD7 is the key player in the early morphogenetic events that build the heart's structure, while CHD4 helps lock in the identity of heart cells as they differentiate. This refined view points us toward which specific gene to look at when studying different types of heart defects, and it opens the door to asking whether these remodelers work together or buffer each other's loss.'
The review, published in the World Journal of Pediatrics, is a definitive synthesis of current evidence. The journal has an Impact Factor of 7.3 and a CiteScore of 8.5. The research was supported by multiple Chinese funding agencies, including the National Key Research and Development Program of China and the National Natural Science Foundation of China.
